The global IBS and IBD therapeutics market is set to grow from $33.3 billion in 2025 to $52.6 billion by 2030, at a 9.6% CAGR ...

A new study published in the journal of Clinical Gastroenterology and Hepatology showed that the possibility of vitamin D ...

ACROBiosystems is breaking the chain of chronic suffering and safeguarding intestinal health. Learn how in this article.

Management of Crohn's disease is being transformed. A new head-to-head trial published in The Lancet shows superiority of ...

Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.